Succasunna, New Jersey *****
Home: 973-***-****
Mobile: 973-***-****
eMail: ***********@*********.***
Neil W. Drucker
Professional Experience
Executive Vice President, Business Development
PACE, Inc
Division of Lowe Healthcare
Parsippany, NJ
Responsible for building new business opportunities, introducing agency to new prospective clients, and
obtaining invitations to pitch for new Agency of Record assignments. Successful in getting PACE added
to approved agency roster at Wyeth. Successfully led pitch and won Agency of Record assignment for
Nexavar US and Global. Because of quality of work on Nexavar, Lowe Healthcare/IPG invited to pitch for
network assignment for Bayer. These efforts also led to pitches for Kogenate (PACE) and Bayer
W omen’s Health (Interlink). Additional New Business activities: Celgene (Awarded Revlimid, Vidaza),
AAMDS (Awarded Account), Abbott (Simcor), Bayer Aspirin for Pain (Global), Bayer Aspirin for Cardio
(Global), Jazz Pharmaceuticals, LuxBio Sciences, Cumberland Pharmaceuticals, bioTheranostics, and
Cephalon.
7/04 to 7/06
EXECUTIVE VICE PRESIDENT, Account Services
Saatchi & Saatchi Healthcare Innovations
Division of Saatchi & Saatchi Healthcare, Publicis Healthcare Group
Langhorne, PA
Direct Wyeth business: Altace, a $600 million dollar brand co-marketed with King Pharmaceuticals, and
the Wyeth Oncology franchise (Mylotarg, Neumega, and the launch of Torisel (temsirolimus), a new
targeted mTOR inhibitor for Renal Cell Carcinoma. Direct reports include 2 VP Account Supervisors and
an Account Executive on the Wyeth business. Altace management includes professional, consumer, and
managed markets. Achieved/surpassed revenue growth and goals on all core businesses.
In addition, pitched and won new clients: Genmab, Inc. a biotech company launching targeted MAB’s for
Oncology, Schering Managed Care’s Signature Websites – My Health Zone and Gateway for Health,
Smith & Nephew (SpineCath), an orthopedic and endoscopic device manufacturer, and Medpointe
(Felbatol).
Directed majority of the new business pitches during 2004-2005 including: Myobloc (Solstice), HuMAX-
CD4 (Genmab), Silenor (Somaxon), Crixal-Alize (Essilor), Zelapar (Valient), SpineCath (Smith &
Nephew), Ketek (Sanofi-Aventis).
3/99 to 7/04
PRESIDENT
N8 Digital
Division of Healthcare Resources Group, Saatchi & Saatchi Healthcare, Publicis Healthcare Group
New York, New York
Started N8 Digital, an eMarketing/eLearning Consulting and Production Company. Services included
eMarketing planning, eLearning design, Patient Education/Persistency, Website development, hybrid CD-
ROMs, and customized software applications. Opened offices in New York and New Jersey. Major
clients include Aventis, Wyeth Ayerst, Cygnus, Berlex, Elan, Pharmacia Oncology, AstraZeneca, Solvay,
Rutger’s University, NovoNordisk, Altana and internal HRG divisions. Established N8 Digital as the
largest healthcare Website development company within the Saatchi & Saatchi Worldwide Network.
Developed unique programs in Oncology and a comprehensive eLearning/eMarkeitng Suite of Products –
6 Summit Lane
Succasunna, New Jersey 07876
Home: 973-***-****
Mobile: 973-***-****
eMail: ***********@*********.***
Neil W. Drucker
Professional Experience
CDWEB-powered iSuite.
6 Summit Lane
Succasunna, New Jersey 07876
Home: 973-***-****
Mobile: 973-***-****
eMail: ***********@*********.***
Neil W. Drucker
Professional Experience
11/95 to 3/99
SENIOR GROUP VICE PRESIDENT, MANAGING DIRECTOR (9/97 TO 3/99)
SENIOR VICE PRESIDENT, MANAGEMENT SUPERVISOR (11/95 TO 8/97)
Harrison Wilson & Associates
Parsippany, New Jersey
Built and directed e-CME, new interactive and advanced technologies division of HW&A. Eighteen direct
reports; responsibilities extended to account service (Rhône-Poulenc Rorer Pharmaceuticals: Combipatch
(new product launch), Medcomm (consultant), DDAVP Nasal Spray (consultant); Pfizer: Managed Care
(Customer Marketing Group); BMS: Serzone, Maxipime; Novartis: Exelon; Biotech General: Oxandrin;
Ortho Biotech: Procrit; Interactive Development Team - CGI. Billables climbed over 300% in 3 years.
8/91 to 11/95
VICE PRESIDENT, ACCOUNT GROUP SUPERVISOR (5/94 TO 11/95)
VICE PRESIDENT, ACCOUNT SUPERVISOR (11/91 TO 5/94)
ACCOUNT SUPERVISOR (8/91 TO 11/91)
Klemtner Advertising
New York, New York
Managed Account Supervisor and Account Executive on Wyeth-Ayerst Laboratories (Norplant System)
and Rhône-Poulenc Rorer (DDAVP Nasal Spray/Tablets), and Berlex Laboratories (Trilevlen/Levlen OCs,
Quinaglute). Responsible for professional, trade and consumer promotion (DDAVP) and for the
professional promotion and special projects for Wyeth Ayerst (Norplant). Managed Account Executive on
Berlex Laboratories and managed Wyeth Ayerst (Norplant) and Rhone-Poulenc Rorer (DDAVP).
Responsible for the preparation of 1992 tactical brand plans.
10/90 to 7/91
SENIOR PRODUCT MANAGER
Wallace Laboratories
Cranbury, New Jersey
Complete day-to-day responsibility for the management of new Doral (quazepam) Tablets brand.
Created/executed a comprehensive marketing plan with an $8.025 million promotion budget. Conducted
largest Phase IV clinical trial on hypnotic agents with psychiatrists.
6/88 to 10/90
SENIOR PRODUCT MANAGER
GynoPharma Inc.
Somerville, New Jersey
Complete day-to-day responsibility for the management of the ParaGard IUD including development of
the marketing plan, selling strategies, and interface with all public relations efforts. Responsible for the
product launch and day-to-day management for the Norcept-E 1/35 brand of oral contraceptives including
development of the marketing plan, retailer and wholesaler selling programs and sales representative
selling strategy.
6 Summit Lane
Succasunna, New Jersey 07876
Home: 973-***-****
Mobile: 973-***-****
eMail: ***********@*********.***
Neil W. Drucker
Professional Experience
9/75 to 5/88
PRODUCT MANAGER (9/86 TO 5/88)
ASSOCIATE PRODUCT MANAGER (9/85-9/86)
MARKETING PLANNER (12/84-8/85)
Sandoz, Inc.: Sandoz Pharmaceuticals Division
East Hanover, New Jersey
Complete P&L and day-to-day management responsibility for the Tavist product line representing $58.4
million in annual sales. Increased sales in Tavist product line 42% while maintaining target profit levels;
products managed represent 11% of total division revenues. Spearheaded "innovative' highly acclaimed
Tavist-1 newspaper advertising campaign in 25 major markets which changed and expanded the
industry's approach on direct to the consumer marketing of prescription drugs.
Responsible for management of Embolex and Sandoglobulin. Developed pre-marketing program for Total
Hip Replacement Indication for Embolex. Created new marketing strategy for Sandoglobulin which
enabled Sandoz to recapture lost business and target new accounts in a highly competitive market.
Responsible for researching and formulating strategies and marketing campaigns, and general market
research for several high-tech product lines including Embolex and Cyclosporin.
SENIOR TECHNICAL REPRESENTATIVE (1/81 to 11/84)
Promoted to develop sales and awareness of new and existing product lines with area hospitals, medical
centers, mental health institutions and nursing homes. Specialty coverage included: Internal Medicine,
Nephrology, OB/GYN, Cardiology, Psychiatry, Allergy/Immunology, Dermatology, Primary Care, and
Endocrinology.
Served in Sales Trainer capacity; accompanied in the field, providing sales and motivational techniques
for an 18 member nursing home sales staff in a 3-state area. Achieved #1 region in the country for the
sale of Tavist.
SALES REPRESENTATIVE (9/75 to 1/81)
As a result of consistent performance working with physicians, hospitals, major retail chain pharmacies
and drug wholesalers, recipient of:
. Marketing Award for merchandise design display;
. 3 Summit Awards and membership in the President's Club.
EDUCATION: MBA, Business Administration, Oakland University,
Rochester, Michigan, 1986.
Completed 2 years medical school, Wayne State University School of Medicine,
1975.
BA Biology, Magna Cum Laude, Queens College, CUNY 1973.
Honors: Phi Beta Kappa, Certified Medical Representative
Married, 2 children
REFERENCES: Available upon request.